Cargando…
Patiromer utility as an adjunct treatment in patients needing urgent hyperkalaemia management (PLATINUM): design of a multicentre, randomised, double-blind, placebo-controlled, parallel-group study
INTRODUCTION: Hyperkalaemia is common, life-threatening and often requires emergency department (ED) management; however, no standardised ED treatment protocol exists. Common treatments transiently reducing serum potassium (K(+)) (including albuterol, glucose and insulin) may cause hypoglycaemia. We...
Autores principales: | Rafique, Zubaid, Budden, Jeffrey, Quinn, Carol Moreno, Duanmu, Youyou, Safdar, Basmah, Bischof, Jason J, Driver, Brian E, Herzog, Charles A, Weir, Matthew R, Singer, Adam J, Boone, Stephen, Soto-Ruiz, Karina M, Peacock, W Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277034/ https://www.ncbi.nlm.nih.gov/pubmed/37308268 http://dx.doi.org/10.1136/bmjopen-2022-071311 |
Ejemplares similares
-
Patiromer sorbitex calcium for hyperkalaemia
Publicado: (2019) -
Current treatment and unmet needs of hyperkalaemia in the emergency department
por: Rafique, Zubaid, et al.
Publicado: (2019) -
Pharmacology of new treatments for hyperkalaemia: patiromer and sodium zirconium cyclosilicate
por: Rosano, Giuseppe M C, et al.
Publicado: (2019) -
Management of hyperkalaemia in acute kidney injury in a heart failure patient with patiromer
por: Slawik, Jonathan, et al.
Publicado: (2020) -
The Cost Effectiveness of Patiromer for the Treatment of Hyperkalaemia in Patients with Chronic Kidney Disease with and without Heart Failure in Ireland
por: Ward, Thomas, et al.
Publicado: (2022)